Novo Nordisk A/S (NYSE:NVO) has partnered with Anthropic to use Claude models and Claude Science in its research and ...
The Ozempic maker is partnering with the AI firm to speed up drug development.
Asianet Newsable on MSN
Novo Nordisk taps Anthropic’s Claude Science to speed up drug discovery — here’s everything investors need to know
Novo will use Anthropic’s Claude Science in R&D to tackle scientific and drug discovery challenges, aiming to develop new ...
Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science ...
The Danish pharmaceutical company is best known for the weight-loss drug Wegovy. Its latest partnership aims to find the next ...
Cryptopolitan on MSN
Novo Nordisk and Anthropic collaborate to advance drug development with Claude
Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them ...
Novo Nordisk and Anthropic announced a collaboration to deploy Claude Science and other frontier AI models to speed up drug ...
Novo Nordisk (NVO) stock rose 4% after announcing an Anthropic AI deal and receiving a European approval recommendation for ...
Novo Nordisk (NVO) stock jumped 4% after unveiling an AI collaboration with Anthropic and securing European approval recommendation for Frehemgo.
Introduction"The improvement in AI capabilities holds the potential to compress a century's worth of breakthroughs in biology ...
Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic's frontier AI models and test the Claude Science workbench in specific research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results